{
    "nct_id": "NCT03533257",
    "title": "Phase II Study to Assess the Safety, Tolerability, and Target Engagement of AMX0035, a Fixed Combination of Sodium Phenylbutyrate and Tauroursodeoxycholic Acid for the Treatment of Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2025-03-04",
    "description_brief": "The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD).",
    "description_detailed": "The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD). The study is designed to evaluate the safety, tolerability, drug target engagement and neurobiological effects of treatment with AMX0035 over 24 weeks. The study is designed to yield deep phenotyping insight for the purposes of demonstrating the effects of AMX0035 on mechanistic targets of engagement and disease biology. The study will evaluate diverse disease-relevant markers and produce an informative dataset that will allow for evaluation and correlation of imaging-based markers, neurobiological changes, functional measures, and cognitive outcomes. Participants receive orally administered study drug twice daily for a treatment duration of approximately 24 weeks and attend clinic visits at Screening, Baseline, Week 6, Week 12, Week 18, and Week 24.",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Active (AMX0035)",
                    "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "Taste-matched Placebo\n\nPlacebo: Placebo"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "51"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "44"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "41"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "42"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Enrolled in other study, terminated by Sponsor, other",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "Safety Population",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Active (AMX0035)",
                    "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "Taste-matched Placebo"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "51"
                        },
                        {
                            "groupId": "BG001",
                            "value": "44"
                        },
                        {
                            "groupId": "BG002",
                            "value": "95"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "70.7",
                                            "spread": "7.69"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "70.7",
                                            "spread": "7.30"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "70.7",
                                            "spread": "7.48"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "43"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "52"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "49"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "92"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "95"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "ApoE4 Gene Group 1",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Carrier",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "64"
                                        }
                                    ]
                                },
                                {
                                    "title": "Non-carrier",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "28"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "ApeE4 Gene Group 2",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "1 allele",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "29"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "47"
                                        }
                                    ]
                                },
                                {
                                    "title": "2 alleles",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17"
                                        }
                                    ]
                                },
                                {
                                    "title": "Non-carrier",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "28"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Number of Participants With Treatment-Emergent Adverse Event (TEAEs)",
                    "description": "Comparison between the AMX0035 Group and Placebo of the number of participants with TEAEs",
                    "populationDescription": "Safety Population",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "From first dose to 24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "34"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "26"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Effect of Treatment on a Global Composite Statistical Test of Cognition, Function, and Neuroanatomy (GST)",
                    "description": "Change from Baseline in GST (global statistical test combining three measures relevant to disease trajectory (cognition \\[MADCOMS: Mild/Moderate Alzheimer's Disease Composite Score\\], function \\[FAQ: Functional Activities Questionnaire\\], and total hippocampal volume on magnetic resonance imaging)) for AMX0035 relative to placebo. For MADCOMS and FAQ, a higher score indicates a worse outcome. A larger hippocampal volume is better, so it was reversed before being normalized. Each of the three were normalized against respective baseline means and standard deviations. The mean of the three normalized scores is the final GST. A higher GST score indicates a worse outcome. Standard deviations above the mean are worse; standard deviations below the mean are better.\n\nThe expected value of the GST at baseline is 0 because it is the mean of three z-scores whose expected values at baseline are 0. AD is multifaceted and the GST was designed to be sensitive to changes in multiple dimensions.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.24",
                                            "spread": "0.049"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.17",
                                            "spread": "0.052"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3654",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Effect of Treatment on Cognition",
                    "description": "Impact of AMX0035 on clinical symptoms as measured by Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog). Scoring is in the range of 0 to 90 with a higher score indicating greater cognitive impairment.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.26",
                                            "spread": "1.402"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.52",
                                            "spread": "1.496"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.6698",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Effect of Treatment on Functioning",
                    "description": "Impact of AMX0035 on Functional Activities Questionnaire (FAQ) scores. FAQ total score can range from 0 to 30, with higher scores indicating less functional independence.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.61",
                                            "spread": "0.790"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.59",
                                            "spread": "0.845"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3086",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Effect of Treatment on Dementia Severity",
                    "description": "Impact of AMX0035 on Dementia Severity Rating Scale (DSRS) scores. Total score can range from 0 to 54, with higher scores indicating greater severity of dementia.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.34",
                                            "spread": "0.595"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.81",
                                            "spread": "0.636"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.5552",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Effect of Treatment on Cognitive Impairment",
                    "description": "Impact of AMX0035 on the Montreal Cognitive Assessment (MoCA) scores. MoCA scores can range from 0 to 30, with lower scores indicating greater cognitive impairment.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.18",
                                            "spread": "0.483"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.70",
                                            "spread": "0.512"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.0361",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Effect of Treatment on Neuropsychiatric Symptoms",
                    "description": "Impact of AMX0035 on neuropsychiatric symptoms as assessed by the Neuropsychiatric Inventory (NPI). The total score ranges from 0 to 36, with higher scores indicating a greater severity of symptoms.",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.15",
                                            "spread": "0.490"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.46",
                                            "spread": "0.526"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3585",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Regional Brain Volume",
                    "description": "Impact of AMX0035 on levels of hippocampal atrophy, as assessed by volumetric Magnetic Resonance Imaging (vMRI)",
                    "populationDescription": "ITT population",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "mm^3",
                    "timeFrame": "24 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Active (AMX0035)",
                            "description": "AMX0035 twice daily--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Taste-matched Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "51"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "44"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-75.18",
                                            "spread": "25.429"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-70.78",
                                            "spread": "23.308"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.8996",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "The analysis assessed the difference in estimated change-from-baseline values at the 24-week model estimate using LS means estimates from the MMRM."
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "24 weeks",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Active (AMX0035)",
                    "description": "AMX0035--a combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO)",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 51,
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 51,
                    "otherNumAffected": 12,
                    "otherNumAtRisk": 51
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "Taste-matched Placebo",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 44,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 44,
                    "otherNumAffected": 6,
                    "otherNumAtRisk": 44
                }
            ],
            "seriousEvents": [
                {
                    "term": "Depression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 44
                        }
                    ]
                },
                {
                    "term": "Burns third degree",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 44
                        }
                    ]
                },
                {
                    "term": "Pneumonia viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 44
                        }
                    ]
                },
                {
                    "term": "Cerebral infarction",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 44
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 8,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 44
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 23.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 51
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 5,
                            "numAtRisk": 44
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Chief Medical Officer",
                "organization": "Amylyx Pharmaceuticals, Inc.",
                "email": "medinfo@amylyx.com",
                "phone": "(877) 374-1208"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "AMX0035 (fixed-dose combination of sodium phenylbutyrate and tauroursodeoxycholic acid / taurursodiol)"
    ],
    "placebo": [
        "Placebo"
    ],
    "explanation_target": [
        "Reason: The trial is a 24-week, randomized, double-blind, placebo-controlled Phase II study in participants with MCI or early dementia due to Alzheimer\u2019s disease evaluating AMX0035 for safety, tolerability, target engagement and neurobiological effects. \ue200cite\ue202turn0search9\ue202turn0search0\ue201",
        "Act: AMX0035 is a proprietary oral fixed\u2011dose combination of two small molecules \u2014 sodium phenylbutyrate (PB) and tauroursodeoxycholic acid/taurursodiol (TUDCA/TURSO) \u2014 designed to mitigate neurodegeneration by targeting endoplasmic reticulum (ER) stress and mitochondrial dysfunction (reducing unfolded protein response and apoptosis pathways). These are small\u2011molecule mechanisms aimed at disease biology rather than a biologic or purely symptomatic cognitive enhancer. \ue200cite\ue202turn0search6\ue202turn0search2\ue202turn0search5\ue201",
        "Reflect: Given AMX0035 consists of two small molecules with proposed disease\u2011modifying mechanisms (ER stress/mitochondrial protection) in neurodegeneration, the correct category is 'disease-targeted small molecule'. There is no indication in the trial description that this is a biologic (e.g., antibody or vaccine), a symptomatic-only cognitive enhancer, or an intervention targeted primarily at neuropsychiatric/behavioral symptoms. \ue200cite\ue202turn0search6\ue202turn0search2\ue201",
        "Web search sources used (key results): Phase II trial listing and description (NCT03533257 / study summary). \ue200cite\ue202turn0search9\ue202turn0search0\ue201",
        "AMX0035 / Relyvrio mechanism and regulatory context (Amylyx / Drugs.com / CenterWatch summaries describing PB + taurursodiol, mechanisms, and clinical development). \ue200cite\ue202turn0search6\ue202turn0search2\ue202turn0search5\ue201",
        "Notes/uncertainty: None critical \u2014 AMX0035 is well\u2011described in the literature as a small\u2011molecule fixed combination targeting cellular stress pathways; classification as 'disease-targeted small molecule' follows directly from those mechanisms and the trial's disease\u2011focused aims. \ue200cite\ue202turn0search6\ue202turn0search2\ue201"
    ],
    "agent_type": "R) Multi-target",
    "explanation_agent": [
        "Reason: The trial tests AMX0035 (fixed combination of sodium phenylbutyrate and tauroursodeoxycholic acid/taurursodiol), a disease\u2011targeted small\u2011molecule combination whose described mechanism explicitly targets both endoplasmic reticulum (ER) stress / unfolded protein response (proteostasis) and mitochondrial dysfunction / apoptosis (bioenergetics / cell\u2011death pathways). These two distinct mechanistic foci map to CADRO categories I) Proteostasis/Proteinopathies and J) Metabolism and Bioenergetics (and overlap with H) Cell Death), so the intervention is best classified as multi\u2011target. \ue200cite\ue202turn0search0\ue202turn1search3\ue202turn1search1\ue201",
        "Act: Extracted details \u2014 drug: AMX0035 (sodium phenylbutyrate + taurursodiol); stated targets/mechanisms: reduction of unfolded protein response / ER stress (phenylbutyrate acts as a chemical chaperone / UPR modulator) and reduction of mitochondrial\u2011dependent apoptosis / mitochondrial protection (taurursodiol). The PEGASUS (NCT03533257) Phase II trial description confirms the study\u2019s aim to evaluate target engagement on those neurodegenerative pathways. Because two mechanistic pathways are explicitly targeted, I assign 'R) Multi-target'. \ue200cite\ue202turn0search0\ue202turn1search1\ue202turn1search3\ue201",
        "Reflect: This classification aligns with the PEGASUS trial documents and Amylyx descriptions that describe AMX0035 as acting on ER and mitochondrial pathways rather than a single canonical AD target (e.g., amyloid or tau). If one had to choose a single CADRO category, I) Proteostasis or J) Metabolism/Bioenergetics could be defensible individually, but the trial and drug description clearly implicate both\u2014so 'R) Multi\u2011target' is the most accurate CADRO mapping. No evidence in the trial description indicates a purely symptomatic or diagnostic (non\u2011therapeutic) intervention, so 'T) Other' is not appropriate. \ue200cite\ue202turn1search3\ue202turn0search2\ue201",
        "Web sources used (key results):",
        "- AMX0035 / Relyvrio mechanism summary (Drugs.com): describes PB reducing the unfolded protein response and TURSO reducing apoptosis; targets ER and mitochondrial\u2011dependent neuronal degeneration. \ue200cite\ue202turn0search0\ue201",
        "- Amylyx press/investor materials describing PEGASUS trial and AMX0035 as targeting mitochondrial and ER pathways. \ue200cite\ue202turn1search3\ue202turn0search4\ue201",
        "- Clinical trial registry (PEGASUS, NCT03533257) \u2014 Phase 2, 24\u2011week randomized, placebo\u2011controlled study to evaluate safety, tolerability, target engagement and neurobiological effects of AMX0035 in MCI/early AD. \ue200cite\ue202turn1search1\ue201"
    ]
}